Clinical Trial Update: A Single Centre Study to Evaluate 3 Ophthalmic Formulations in Healthy Subjects [Phase 1]

View source ↗

Summary

Phase 1 study evaluating three ophthalmic formulations in healthy subjects has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glaucoma
• Ocular Hypertension

Snippet

Sponsor: Amakem, NV | Conditions: Glaucoma, Ocular Hypertension | Phase 1 | Status: COMPLETED